The effect of infliximab on oxidative stress in chronic inflammatory joint disease

Current Medical Research and Opinion

Volumn 23, Issue 6, 2007, Pages 1259-1267

  Túnez, Isaac ^a   Feijoo M ^b   Huerta, G ^b   Montilla, P ^a   Munoz E ^c   Ruiz A ^c   Collantes, E ^c  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Ankylosing spondylitis; Chronic inflammatory joint disease; Infliximab; Psoriatic arthritis; Reactive oxygen species; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INFLIXIMAB; SUPEROXIDE DISMUTASE;

ADULT; ANKYLOSING SPONDYLITIS; ANTIOXIDANT ACTIVITY; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CHRONIC DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT GLOBAL ASSESSMENT OF THE DISEASE; PSORIATIC ARTHRITIS; QUANTITATIVE ASSAY; RHEUMATOID ARTHRITIS;

ADULT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS; BLOOD SEDIMENTATION; CATALASE; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; JOINT DISEASES; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SUPEROXIDE DISMUTASE;

EID: 34347209779     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X187955     Document Type: Conference Paper

References (32)

1. Halliwell B. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis 1995;54:505-10
2. Nurcombe HL, Bucknall RC, Edwards SW. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo. Ann Rheum Dis 1991;50: 147-53
3. Ho KJ, Chen PQ, Chang CY, et al. The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence. Ann Rheum Dis 2000;59:338-41
4. Biemond A, Swaak AJG, Koster JF. Protective factors against oxygen free radicals and hydrogen peroxide in rheumatoid arthritis synovial fluid. Arthr Rheum 1984;27:750-65
5. Basu S, Whiteman M, Mattey DL, et al. Raised levels of F2-isoprostanes and prostaglandin F2a in different rheumatic diseases. Ann Rheum Dis 2001;60:627-31
6. Kamanli A, Nazairoglu M, Aydilek N, et al. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 2004;22:53-7
7. Alsharif NZ, Hassoun E, Bagchi M, et al. The effect of anti-TNF-alpha and dexamethasone on TCDD-induced oxidative stress in mice. Pharmacology 1994;48:127-36
8. Vuolteenaho K, Moilanen T, Hamalainen M, et al. Effects of TNF-alpha-antagonists on nitric oxide production in human cartilage. Osteoarthr Cartil 2002;10:327-32
9. Miesel R, Murphy MP, Kroger H. Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels for tumor necrosis factor alpha in plasma. Free Radic Res 1996;25:161-9
10. Grinnell S, Yoshida K, Jasin HE. Responses of lymphocytes of patients with rheumatoid arthritis to IgG modified by oxygen radicals or peroxynitrite. Arthritis Rheum 2005;52:80-3
11. Hein GE, Köhler M, Oelzner P, et al. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatol Int 2005;26:137-41
12. Clegg DO, Ward JR. Diagnostic criteria in rheumatoid arthritis. Scand J Rheumatol 1987;65:3-11
13. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;37:361-8
14. Calin A, Nakache JP, Gueguen A, et al. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 1999;38:878-82
15. Levine RL, Garland D, Olivier CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-78
16. Flohé L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984;105:114-21
17. Aebi H, Catalase in vitro. Methods Enzymol 1984;105:121-6
18. Pattichis L, Louca L, Giover V. Quantitation of soluble superoxide dismutase in rat strata, based on the inhibition of nitrite formation from hydroxylammonium chloride. Anal Biochem 1994;193:265-75
19. Zhou Z, Wang L, Song Z, et al. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol 2003;163:1137-46
20. Liu MY, Cheng YJ, Chen CK, et al. Coexposure of lead- and lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-initiated oxidative stress and TNF-alpha. Shock 2005;23:360-4
21. Jikimoto T, Nishikubo Y, Koshiba M, et al. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2001;38:765-72
22. Yazici C, Köse K, Calis M, et al. Protein oxidation status in patients with ankylosing spondylitis. Rheumatology 2004;43:1235-9
23. Oruc N, Ozutemiz AO, Yukselen V, et al. Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas 2005;28:1-8
24. Little M.A, Bhangal G, Smyth CL, et al. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis. J Am Soc Nephrol 2006;17:160-69
25. Hadjigogos K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 2003;45:7-13
26. Baskol G, Demir H, Baskol M, et al. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 2005;38:951-5
27. Sarban S, Kocyigit A, Yazar M, et al. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005;38:981-86
28. Giustarini D, Lorenzini S, Rossi R, et al. Altered thiol pattern in plasma of subjects affected by rheumatoid arthritis. Clin Exp Rheumatol 2005;23:205-12
29. Shah R, Raska K, Tiku M.L. The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage. Arth Rheum 2005;52:2799-807
30. Regan E, Flannelly J, Bowler R, et al. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arth Rheum 2005;52, 3479-3491
31. Mezes M, Par A, Bartosiewicz G, et al. Vitamin E content and lipid peroxidation of blood in some chronic inflammatory diseases. Acta Physiol Hung 1987;69:133-38
32. Ozgocmen S, Sogut S, Ardicoglu O, et al. Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 2004; 24:80-83